# SYR-472 Open-label Study

> **NCT01751360** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 14 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** SYR-472

## Key facts

- **NCT ID:** NCT01751360
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-01
- **Primary completion:** 2013-08-01
- **Final completion:** 2013-08-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01751360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01751360, "SYR-472 Open-label Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01751360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*